Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma Treatments

SIMPLE SUMMARY: Recently, nivolumab, pembrolizumab, both immune-checkpoint inhibitors (ICIs) and the combination of dabrafenib plus trametinib (D + T) were registered as adjuvant melanoma treatments, to prevent recurrence. The aim of this paper was to retrospectively review the benefits and risks of...

Descripción completa

Detalles Bibliográficos
Autores principales: van Laar, Sylvia A., Kapiteijn, Ellen, Gombert-Handoko, Kim B., Guchelaar, Henk-Jan, Zwaveling, Juliette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657798/
https://www.ncbi.nlm.nih.gov/pubmed/36358844
http://dx.doi.org/10.3390/cancers14215426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657798/
https://www.ncbi.nlm.nih.gov/pubmed/36358844
http://dx.doi.org/10.3390/cancers14215426

Ejemplares similares